Betaproteobacteria

A class of Gram-negative bacteria within the phylum Proteobacteria that has emerged as a causal risk factor for schizophrenia and bipolar disorder through Mendelian randomization studies. Betaproteobacteria includes genera with notable metal tolerance — particularly within the order Burkholderiales — explaining their enrichment in heavy-metal-contaminated environments and potentially connecting environmental metal exposure to neuropsychiatric disease via the gut-brain axis.

Taxonomy

  • Class Betaproteobacteria, phylum Proteobacteria.
  • Key gut-relevant orders: Burkholderiales (includes oxalobacter, parasutterella, Sutterella), Neisseriales (includes neisseria meningitidis).
  • Taxonomic note: some classification schemes have reclassified Betaproteobacteria as a subclass within Gammaproteobacteria based on phylogenomics; the traditional class-level designation is retained here for consistency with MR studies that used this taxonomy.

Metal Dependencies and Tolerance

Iron:

  • Betaproteobacteria encode diverse iron acquisition systems including siderophore receptors and TonB-dependent transporters.
  • The class includes both iron-dependent commensals and aggressive iron competitors that thrive in iron-replete inflammatory environments.

Nickel and Heavy Metal Tolerance:

  • Burkholderiales, the largest gut-relevant order within Betaproteobacteria, includes species that thrive in heavy-metal-contaminated soils and environments.
  • Metal efflux pumps (CzcCBA for Cd/Zn/Co, NccCBA for Ni/Co/Cd) are widespread in Betaproteobacteria, providing survival advantages in metal-stressed environments.
  • This metal tolerance creates a potential pathway: environmental heavy metal exposure → selective enrichment of metal-tolerant Betaproteobacteria in the gut → neuropsychiatric effects via the gut-brain axis.

Ecological Role

In the Healthy Gut

Betaproteobacteria are minor members of the healthy gut microbiota, typically comprising <5% of the total community. Parasutterella and oxalobacter are the best-characterized gut-resident genera.

In Dysbiosis

Betaproteobacteria expansion is observed in neuropsychiatric conditions and in individuals with elevated heavy metal exposure. The class's metal tolerance mechanisms provide a competitive advantage when dietary or environmental metals create selection pressure against metal-sensitive commensals.

Conditions Associated

Schizophrenia (Causal Risk Factor)

Class Betaproteobacteria is causally linked to schizophrenia (OR = 1.13, 95% CI 1.01-1.27, p = 0.027) [1]. Betaproteobacteria has been previously associated with cognitive impairment in schizophrenia patients, suggesting a specific neurological pathway. Effective intervention requires suppressing both Betaproteobacteria and clostridia (OR 1.16) while restoring desulfovibrio and veillonellaceae — the two-sided ecological engineering principle.

Bipolar Disorder

Class Betaproteobacteria is causally linked to bipolar disorder via a separate Mendelian randomization study [2], suggesting a shared gut-brain mechanism across psychotic spectrum disorders.

Epilepsy

Betaproteobacteria (class) and Burkholderiales (order) are MR risk factors for epilepsy (OR = 1.357 and 1.336 respectively), further supporting the class's role in neurological disease via the gut-brain axis.

Key Studies

  • [1] (Mendelian randomization, n=148,984) — Established Betaproteobacteria as a causal schizophrenia risk factor; bidirectional MR confirmed directionality.
  • [2] (Mendelian randomization) — Causally linked Betaproteobacteria to bipolar disorder.

Open Questions

  1. Does environmental heavy metal exposure drive Betaproteobacteria enrichment in neuropsychiatric patients? The metal tolerance of Burkholderiales provides a mechanistic hypothesis, but no study has measured both metal exposure and Betaproteobacteria abundance in psychiatric cohorts.
  2. Which Betaproteobacteria genera mediate the schizophrenia signal? Class-level MR data cannot distinguish between Parasutterella, Sutterella, Oxalobacter, and other gut-resident genera.
  3. Does Betaproteobacteria suppression improve cognitive outcomes in schizophrenia? The association with cognitive impairment suggests a specific intervention target, but no RCT has tested this.

Cross-References

  • schizophrenia — causal risk factor via MR
  • clostridia — co-identified as schizophrenia risk taxon in the same MR study
  • veillonellaceae — causally protective counterpart in schizophrenia ecology
  • desulfovibrio — causally protective counterpart in schizophrenia ecology
  • parasutterella — a key gut-resident genus within Betaproteobacteria
  • oxalobacter — another gut-relevant genus; Burkholderiales order
  • neisseria meningitidis — a pathogenic Betaproteobacteria outside the gut niche
  • epilepsy — Betaproteobacteria and Burkholderiales as MR risk factors

References (8)

  1. Keer Zhou, Ancha Baranova, Hongbao Cao et al. (2024). Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian Randomization. Schizophrenia (Nature Partner Journal). doi:10.1038/s41537-024-00497-7
  2. Jing-Jing Ni, Qian Xu, Shan-Shan Yan et al. (2022). Ni 2022 — Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology. doi:10.3389/fmicb.2021.737197
  3. Ming Yuan, Dong Li, Zhe Zhang et al. (2018). Yuan 2018 — Endometriosis Induces Gut Microbiota Alterations in Mice. Human Reproduction. doi:10.1093/humrep/dex372
  4. Tung Hoang, Minjung Kim, Ji Won Park et al. (2023). Dysbiotic microbiome variation in colorectal cancer patients is linked to lifestyles and metabolic diseases. BMC Microbiology. doi:10.1186/s12866-023-02771-7
  5. Fang L, Ning J (2024). Fang & Ning 2024 — Recent Advances in Gut Microbiota and Thyroid Disease: Pathogenesis and Therapeutics. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2024.1465928
  6. Wang M, Zhu Y (2025). Wang & Zhu 2025 — Gut Microbiome Versus Thyroid Cancer: Association and Clinical Implications (Review). Oncology Letters. doi:10.3892/ol.2025.15114
  7. Ni JJ, Xu Q, Yan SS et al. (2022). Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology. doi:10.3389/fmicb.2021.737197
  8. Youjie Zeng, Si Cao, Heng Yang (2023). Roles of gut microbiome in epilepsy risk: a Mendelian randomization study. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1115014